Slaughter and May is advising INEOS Inovyn on the acquisition of the UK's only Ethylene dichloride asset from administration

Slaughter and May is advising INEOS Inovyn on the acquisition of the remaining 50% shareholding in Runcorn MCP Limited, together with the assets and employees associated with EDC production at Runcorn from Vynova Runcorn Limited, following its entry into administration in 2025. The transaction is subject to regulatory approvals and is expected to complete later this year.

The transaction strengthens the continuity of strategically critical chlor‑alkali operations in the UK, underpinning water treatment, chemicals production and food manufacturing.

The transaction will fully integrate the chlor-alkali and EDC value chain under INEOS Inovyn. By bringing these businesses together, INEOS Inovyn will strengthen the long-term future of the site and enhance security of supply for customers.

Around 98% of the chlorine used in drinking water treatment is supplied by Runcorn, highlighting the site’s critical importance to public health and national infrastructure.

The acquisition represents an important step in safeguarding the continuity of strategically critical chlor-alkali operations in the UK. These products are essential for water treatment and food manufacturing and support a wide range of industries, including pharmaceuticals, healthcare and construction. Strengthening the UK's chlor-alkali backbone is vital for strategic autonomy and national resilience.